Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network
Background and Aim. Underlying comorbidities are an emerging risk factor for more severe coronavirus disease 2019 (COVID-19). However, its impact on patients with chronic liver disease (CLD) remains unclear. In addition, there is a paucity of data about whether patients with CLD have an increased ri...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2022/8407990 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849400507076968448 |
|---|---|
| author | Arunkumar Krishnan Laura Prichett Yisi Liu Peng-sheng Ting Saleh A. Alqahtani Amy K. Kim Michelle Ma James P. Hamilton Tinsay A. Woreta Po-Hung Chen |
| author_facet | Arunkumar Krishnan Laura Prichett Yisi Liu Peng-sheng Ting Saleh A. Alqahtani Amy K. Kim Michelle Ma James P. Hamilton Tinsay A. Woreta Po-Hung Chen |
| author_sort | Arunkumar Krishnan |
| collection | DOAJ |
| description | Background and Aim. Underlying comorbidities are an emerging risk factor for more severe coronavirus disease 2019 (COVID-19). However, its impact on patients with chronic liver disease (CLD) remains unclear. In addition, there is a paucity of data about whether patients with CLD have an increased risk of requiring intensive care, vasopressor support, or mechanical ventilation (MV). This study aimed to evaluate the impact of pre-existing LD on the clinical outcome of hospitalized patients with COVID-19. Methods. We studied 2731 patients with known CLD who were hospitalized at the Johns Hopkins Health System with COVID-19 between March 1, 2020, and December 15, 2021. The primary outcome was all-cause mortality, and secondary outcomes were MV and vasopressors. Multivariable Cox regression models were performed to explore factors associated with the outcomes. Results. Overall, 80.1% had severe COVID-19, all-cause mortality was 8.9%, 12.8% required MV, and 11.2% received vasopressor support. Older patients with underlying comorbidities were more likely to have severe COVID-19. There was association between elevated aminotransferases and total bilirubin with more severe COVID-19. Hepatic decompensation was independently associated with all-cause mortality (HR 2.94; 95% CI 1.23–7.06). Alcohol-related liver disease (ALD, HR 2.79, 95% CI, 1.00–8.02) was independently associated with increased risk for MV, and independent factors related to vasopressor support were chronic pulmonary disease and underlying malignancy. Conclusions. COVID-19 infection in patients with CLD is associated with poor outcomes. SARS-CoV-2 infection in patients with hepatic decompensation was associated with an increased risk of in-hospital mortality hazard, and ALD among patients with COVID-19 was associated with an increased hazard for MV. |
| format | Article |
| id | doaj-art-897e3cdb3ffc4ddb96ff84c696aaf6f7 |
| institution | Kabale University |
| issn | 2291-2797 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-897e3cdb3ffc4ddb96ff84c696aaf6f72025-08-20T03:38:01ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972022-01-01202210.1155/2022/8407990Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital NetworkArunkumar Krishnan0Laura Prichett1Yisi Liu2Peng-sheng Ting3Saleh A. Alqahtani4Amy K. Kim5Michelle Ma6James P. Hamilton7Tinsay A. Woreta8Po-Hung Chen9Division of Gastroenterology and HepatologyDepartment of PediatricsDepartment of PediatricsDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyDivision of Gastroenterology and HepatologyBackground and Aim. Underlying comorbidities are an emerging risk factor for more severe coronavirus disease 2019 (COVID-19). However, its impact on patients with chronic liver disease (CLD) remains unclear. In addition, there is a paucity of data about whether patients with CLD have an increased risk of requiring intensive care, vasopressor support, or mechanical ventilation (MV). This study aimed to evaluate the impact of pre-existing LD on the clinical outcome of hospitalized patients with COVID-19. Methods. We studied 2731 patients with known CLD who were hospitalized at the Johns Hopkins Health System with COVID-19 between March 1, 2020, and December 15, 2021. The primary outcome was all-cause mortality, and secondary outcomes were MV and vasopressors. Multivariable Cox regression models were performed to explore factors associated with the outcomes. Results. Overall, 80.1% had severe COVID-19, all-cause mortality was 8.9%, 12.8% required MV, and 11.2% received vasopressor support. Older patients with underlying comorbidities were more likely to have severe COVID-19. There was association between elevated aminotransferases and total bilirubin with more severe COVID-19. Hepatic decompensation was independently associated with all-cause mortality (HR 2.94; 95% CI 1.23–7.06). Alcohol-related liver disease (ALD, HR 2.79, 95% CI, 1.00–8.02) was independently associated with increased risk for MV, and independent factors related to vasopressor support were chronic pulmonary disease and underlying malignancy. Conclusions. COVID-19 infection in patients with CLD is associated with poor outcomes. SARS-CoV-2 infection in patients with hepatic decompensation was associated with an increased risk of in-hospital mortality hazard, and ALD among patients with COVID-19 was associated with an increased hazard for MV.http://dx.doi.org/10.1155/2022/8407990 |
| spellingShingle | Arunkumar Krishnan Laura Prichett Yisi Liu Peng-sheng Ting Saleh A. Alqahtani Amy K. Kim Michelle Ma James P. Hamilton Tinsay A. Woreta Po-Hung Chen Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network Canadian Journal of Gastroenterology and Hepatology |
| title | Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network |
| title_full | Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network |
| title_fullStr | Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network |
| title_full_unstemmed | Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network |
| title_short | Risk of Severe Illness and Risk Factors of Outcomes of COVID-19 in Hospitalized Patients with Chronic Liver Disease in a Major U. S. Hospital Network |
| title_sort | risk of severe illness and risk factors of outcomes of covid 19 in hospitalized patients with chronic liver disease in a major u s hospital network |
| url | http://dx.doi.org/10.1155/2022/8407990 |
| work_keys_str_mv | AT arunkumarkrishnan riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT lauraprichett riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT yisiliu riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT pengshengting riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT salehaalqahtani riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT amykkim riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT michellema riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT jamesphamilton riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT tinsayaworeta riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork AT pohungchen riskofsevereillnessandriskfactorsofoutcomesofcovid19inhospitalizedpatientswithchronicliverdiseaseinamajorushospitalnetwork |